Table of Contents

Experimental and Molecular Therapeutics

• Oral Presentations - Invited Abstracts

  • • • Invited Oral Presentations - Anaplastic Lymphoma Kinase
  • • • Invited Oral Presentations - Future Leaders in Translational Research Special Symposium
  • • • Invited Oral Presentations - New Drugs on the Horizon
  • • • Invited Oral Presentations - Unconventional Therapeutic Targets

• Oral Presentations - Late-Breaking Abstracts

  • • • Late-Breaking Oral Presentations - Novel Antitumor Agents
  • • • Late-Breaking Oral Presentations - Novel Assay Technology
  • • • Late-Breaking Oral Presentations - Pharmacogenetics and Therapeutic Response

• Oral Presentations - Proffered Abstracts

  • • • Proffered Oral Presentations - Determinants of Sensitivity to Small Molecule Therapeutics
  • • • Proffered Oral Presentations - Experimental Therapeutics: Novel Agents and Novel Mechanisms
  • • • Proffered Oral Presentations - New Molecular Targets 5
  • • • Proffered Oral Presentations - Novel Combination Therapies

• Poster Presentations - Late-Breaking Abstracts

  • • • Late-Breaking Poster Presentations - Antibody Technologies
  • • • Late-Breaking Poster Presentations - Antireceptors
  • • • Late-Breaking Poster Presentations - Biological Therapeutic Agents
  • • • Late-Breaking Poster Presentations - Cell Death Pathways and Treatment
  • • • Late-Breaking Poster Presentations - Cellular Responses to Anticancer Drugs
  • • • Late-Breaking Poster Presentations - Combination Chemotherapy
  • • • Late-Breaking Poster Presentations - Drug Discovery
  • • • Late-Breaking Poster Presentations - Functional and Molecular Imaging to Assess Targeted Drug Action
  • • • Late-Breaking Poster Presentations - Growth Factor Receptors and Other Surface Antigens as Targets for Therapy
  • • • Late-Breaking Poster Presentations - HDAC and Methyltransferase Inhibitors
  • • • Late-Breaking Poster Presentations - Identification of Molecular Targets
  • • • Late-Breaking Poster Presentations - Modulation of DNA Repair
  • • • Late-Breaking Poster Presentations - Molecular Classification of Tumors for Diagnosis, Prognosis, and Therapeutic Outcome
  • • • Late-Breaking Poster Presentations - Molecular Pharmacology
  • • • Late-Breaking Poster Presentations - Molecular Targets of Radiation Response
  • • • Late-Breaking Poster Presentations - New Targets
  • • • Late-Breaking Poster Presentations - Novel Antitumor Agents
  • • • Late-Breaking Poster Presentations - Novel Drug Delivery Systems
  • • • Late-Breaking Poster Presentations - Novel Mechanisms
  • • • Late-Breaking Poster Presentations - P-Glycoprotein Structure and Function
  • • • Late-Breaking Poster Presentations - Pharmacogenetics and Therapeutic Response
  • • • Late-Breaking Poster Presentations - Pharmacogenomics
  • • • Late-Breaking Poster Presentations - Pharmacokinetics and Pharmacodynamics
  • • • Late-Breaking Poster Presentations - Proteasome Inhibitors
  • • • Late-Breaking Poster Presentations - Protein Kinase and Phosphatases as Targets for Therapy
  • • • Late-Breaking Poster Presentations - Regulation of Gene Expression in Drug Resistance
  • • • Late-Breaking Poster Presentations - Reversal of Drug Resistance
  • • • Late-Breaking Poster Presentations - Tyrosine Kinase and Phosphatase Inhibitors

• Poster Presentations - Proffered Abstracts

  • • • Poster Presentations - Antibody Technologies
  • • • Poster Presentations - Anticancer Drugs Targeting Cell Cycle and Proliferation
  • • • Poster Presentations - Biochemical Modulators
  • • • Poster Presentations - Cancer Stem Cell Biology 2
  • • • Poster Presentations - Combination Chemotherapy
  • • • Poster Presentations - Combination of Targeted Agents
  • • • Poster Presentations - Combinatorial Approaches to Therapy
  • • • Poster Presentations - DNA Damage and Repair
  • • • Poster Presentations - DNA Damage and Response
  • • • Poster Presentations - Drug Design and Target Validation
  • • • Poster Presentations - Epigenetic Modulators
  • • • Poster Presentations - Gene and Vector-Based Therapy 1
  • • • Poster Presentations - Gene and Vector-Based Therapy 2
  • • • Poster Presentations - Genome Instability and DNA Damage Responses
  • • • Poster Presentations - Intracellular Signal Transduction
  • • • Poster Presentations - Mechanisms of Resistance 1: Targeted Therapeutics
  • • • Poster Presentations - Mechanisms of Resistance 2: Drug Transporters and Agents with Unique Mechanisms of Action
  • • • Poster Presentations - Mechanisms of Resistance 3: Chemotherapeutics
  • • • Poster Presentations - Mechanisms of Resistance 4: Drug Transporters and Chemotherapeutics
  • • • Poster Presentations - Metastasis and Tumor-Host Interactions
  • • • Poster Presentations - Mitotic Kinases and Tubulin-Binding Agents
  • • • Poster Presentations - Modified Antibodies and Oncolytic Viruses
  • • • Poster Presentations - Molecular Diagnostics and Therapeutic Targets 1
  • • • Poster Presentations - Monoclonal Antibodies 2
  • • • Poster Presentations - New Molecular Targets 1: Models, Imaging and Molecular Classification
  • • • Poster Presentations - New Molecular Targets 2: Modulation of DNA Repair and Cell Death Pathways
  • • • Poster Presentations - New Molecular Targets 3: Identification of Molecular Targets I
  • • • Poster Presentations - New Molecular Targets 4: Identification of Molecular Targets II
  • • • Poster Presentations - New Targets
  • • • Poster Presentations - Novel Drug Delivery Systems
  • • • Poster Presentations - Novel Drug Delivery and Assay Technologies
  • • • Poster Presentations - Novel Inhibitors and Mechanisms
  • • • Poster Presentations - Novel Mechanisms of Drug Action
  • • • Poster Presentations - Novel Mechanisms of Drug Action and Signaling Pathways
  • • • Poster Presentations - Oncogenes and Tumor Suppressor Genes 1: New Therapeutic Targets and Strategies
  • • • Poster Presentations - PI3K/mTOR Pathway Inhibitors
  • • • Poster Presentations - Pharmacogenomics and Personalized Medicine 1
  • • • Poster Presentations - Pharmacogenomics and Personalized Medicine 2
  • • • Poster Presentations - Pharmacogenomics and Personalized Medicine 3
  • • • Poster Presentations - Pharmacokinetic, Pharmacogenomic, and Clinical Results of Early-Phase Trials
  • • • Poster Presentations - Preclinical Radiotherapeutics
  • • • Poster Presentations - Receptor Signaling in Endocrine Related Cancers
  • • • Poster Presentations - Receptor Tyrosine Kinase Inhibitors
  • • • Poster Presentations - Regulation of Estrogen Receptor-Positive and -Negative Breast Cancer
  • • • Poster Presentations - Regulation of Protein Stability
  • • • Poster Presentations - Targeting Cell Signaling
  • • • Poster Presentations - Targeting DNA and Chromatin
  • • • Poster Presentations - Targeting Receptors and Cell Surface Antigens
  • • • Poster Presentations - Targeting Signal Transduction Pathways
  • • • Poster Presentations - Tumor Metabolism and Regulation of Apoptosis